Stock listing

Htg Molecular Diagnostics, Inc.

Selected listing: HTGMQ · OTC · USD · US

Htg Molecular Diagnostics, Inc. (OTC:HTGMQ), Commercial Services. Latest release Aug 8, 2023: Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates.

HTGMQ:OTCUSDUSUpdated October 2, 2026
Htg Molecular Diagnostics, Inc. logo
Ticker
OTC:HTGMQ
Asset type
Stock
Sector
Commercial Services
Industry
Miscellaneous Commercial Services
Exchange
OTC
Currency
USD

About Htg Molecular Diagnostics, Inc.

Htg Molecular Diagnostics, Inc. (ticker: HTGMQ) is a public company based in the United States, focusing on molecular diagnostics. Htg Molecular Diagnostics aims to provide innovative solutions in the field of precision medicine.

Latest news from Htg Molecular Diagnostics, Inc.

Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates

August 8, 2023

TransMedics (TMDX) Reports Q2 Loss, Tops Revenue Estimates

August 3, 2023

Integra LifeSciences (IART) Q2 Earnings and Revenues Surpass Estimates

July 26, 2023

All Htg Molecular Diagnostics, Inc. news →

Research Htg Molecular Diagnostics, Inc.

Htg Molecular Diagnostics, Inc. company profile

View the public company page for Htg Molecular Diagnostics, Inc. on 6ix.

Htg Molecular Diagnostics, Inc. news

Read company news and market updates connected to Htg Molecular Diagnostics, Inc..

Htg Molecular Diagnostics, Inc. investor events

Find investor webinars, events, and replay context for Htg Molecular Diagnostics, Inc..